CDEK
← All organizations

Hameln Pharma GmbH

For profitContributed to NMEWebsite ↗

Also known as: HAMELN | HAMELN PHARMA PLUS | HAMELN RDS GMBH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Oct 1, 2016

First marketed drug

Aug 11, 2004

First NDA

Aug 11, 2004

Last known activity

Oct 1, 2016

Timeline

1890s

  1. Jun 1, 1890

    Hameln Pharma GmbH— Founded

2000s

  1. Aug 11, 2004

    diethylenetriaminepentaacetate— NDA Organization

  2. Aug 11, 2004

    diethylenetriaminepentaacetate— NDA Secondary Org

2010s

  1. Sep 10, 2012

    gemcitabine— Marketing Organization

Drugs by trial phase (2 distinct, 1 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (1)

Details

Founded
Hamelin, DE Jun 1, 1890
First NDA
Aug 11, 2004
Last known activity
Oct 1, 2016

Designations held

  • Orphan drug
  • Priority review